.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
AtoZ Botanicals concentrated 58.55% of July 2026 sales in Tincture & Sublingual, with Topical at 35.78% and Edible at 5.68%, and the mix shifted sharply month over month as Tincture & Sublingual grew 46.50% MoM versus 24.47% for Topical and 14.80% for Edible. Year over year, Topical expanded 50.65% compared with 25.20% in Tincture & Sublingual and 12.63% in Edible, while the brand’s average price declined 4.63% YoY against a brand-level sales gain of 32.36% YoY. The implication is a pivot toward volume-led growth anchored in Tincture & Sublingual’s MoM surge while Topical’s faster YoY pace broadens the base, pointing to a two-engine mix where short-term gains come from Tincture & Sublingual and medium-term momentum tilts toward Topical.
With Tincture & Sublingual still the largest contributor at 58.55% share but trailing Topical’s 50.65% YoY expansion, the brand is effectively using price elasticity (average price down 4.63% YoY) to widen reach while protecting its core. The simultaneous 46.50% MoM jump in Tincture & Sublingual and 24.47% MoM rise in Topical suggests inventory and activation emphasis in the core, while Edible’s 14.80% MoM and 12.63% YoY growth indicate optionality rather than a primary growth pillar; the positioning takeaway is to maintain leadership through Tincture & Sublingual intensity while nurturing Topical as the growth hedge to smooth volatility and sustain the 32.36% YoY brand sales trajectory.
Competitive Landscape
AtoZ Botanicals sits at rank #5 in AZ Tincture & Sublingual for July 2026, improving 1 position from #6 year over year and slipping 1 position from #4 in April 2026, which was its peak rank. In the same July 2026 snapshot, SUNO climbed from #5 to #2 while growing sales 253.5% YoY, and Chronic Health fell from #2 to #3 with a 25.1% YoY sales decline, indicating AtoZ Botanicals is holding mid-tier share as momentum consolidates above it. This rank trajectory—up 1 place YoY but down 1 place from the April 2026 peak—implies stabilization rather than breakout, signaling that incremental gains will require displacing competitors now accelerating ahead.
Notable Products
CBD Tangerine Mood Boost Tincture (1400mg CBD) posted the largest movement with a 177.8% month-over-month surge and climbed into rank 4, while CBD Tangerine Tincture (3000mg CBD) fell 33.0% MoM at rank 6, marking the steepest decline; this juxtaposition signals demand shifting within the tincture lineup toward targeted mood and relief cues. Ultra Pain Relief Rub (1000mg CBD, 4oz) rose 56.9% MoM to rank 2 and, alongside CBD Dog Drops Tincture (500mg CBD) at rank 1 with 45.1% MoM growth and $3,744 in July 2026 sales, indicates that two of the top three are Topical and Pet wellness anchors even as three of the top six are Tincture & Sublingual SKUs. The concentration of tinctures in the top six combined with a standout Topical advance implies AtoZ Botanicals is tilting its mix toward higher-potency, problem-solution formats that can be messaged for distinct use cases rather than generalist oils.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
